All subordinate units of the group commend advanced
Release time:
2021-02-10
1# On May 25, at the 2020 work summary meeting held by Yunnan Jianfeng Cement Company, Zhou Jiping made a work report on behalf of Yunnan Jianfeng management team to summarize the production and operation situation in 2020. In 2020, Yunnan Peak overcame the impact of the epidemic and regional new capacity, in the difficult market environment, bucked the trend to create the highest sales in the eight years since the establishment of the plant, to achieve the only sales in southwest Yunnan over last year, the only receivables cleared of the same industry enterprises. Zhou Jiping objectively analyzed the problems and deficiencies in the work, and combined with the actual work in 2020, put forward suggestions on the business objectives, key work plans, work requirements and safeguard measures for 2021. Liu Shenghua, the new general manager of Yunnan Peak, has arranged the work for 2021 in combination with the actual production of Yunnan Peak. The
meeting commended the advanced collectives and individuals in 2020. Fang Xuhua, secretary of the Yunnan Jianfeng Party Branch, deputy general manager, and chairman of the labor union, hopes that all cadres and employees will take the advanced as an example and benchmark, find gaps based on their positions, everyone talks about performance than dedication, and is in line with the advanced, and in the face of new production and operation tasks, Strive to catch up and surpass head-on and reach a new high. At the summary and commendation meeting of the pharmaceutical company held on October 3, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, made an annual work report on behalf of the management team of the pharmaceutical company, he reviewed the main work in 2020 from the aspects of epidemic prevention and control and resumption of production, safety and environmental protection management, product development and technological innovation, marketing management, standardizing production and operation behavior, talent recruitment and training, brand promotion of companies and products, and the work of the party and government work group, and analyzed the industry policy and development trend in 2021. He pointed out that the pharmaceutical industry will still have to face strict industry regulatory policies and severe market competition in 2021, and "recovery, innovation, integration and compliance" will be the key words of China's pharmaceutical economy in 2021. The pharmaceutical company will focus on the overall goal of "reducing costs, expanding the market, increasing speed, and creating benefits", and carry out various production and operation management work in an orderly manner. Jiang Xiaomeng, chairman of
Group Company and chairman of Pharmaceutical Company, attended the meeting. On behalf of the Group Company, he congratulated the advanced collectives and individuals who were commended, affirmed the work of Jianfeng Pharmaceutical in 2020, and put forward requirements for the work of Pharmaceutical Company in 2021. He requested that pharmaceutical companies should create three advantages and create new performance from three aspects: innovative research and development, preparation costs, and API characteristics; make breakthroughs in innovative marketing, management capabilities and thinking, and further refresh marketing capabilities and labor productivity. Reduce costs. At the same time, he hopes that all employees of the pharmaceutical industry will have a sense of urgency, mission and crisis, and complete various indicators of the pharmaceutical company through the efforts of all parties. At the
meeting, the pharmaceutical company awarded the advanced collectives and individuals in 2020. On behalf of the pharmaceutical company, Huang Jinlong signed a new year's economic target responsibility system with the heads of its subordinate enterprises.
This meeting was presided over by Jin Huazhong, Secretary of the Party Committee of Pharmaceutical Company, and summarized the contents of the meeting.
2On the 4th, Guizhou Huangping Jianfeng Cement Company held a summary commendation meeting to commend the advanced collectives and individuals in 2020 and convey the spirit of the group's annual business analysis meeting and summary commendation meeting. Huang Ping Jianfeng Manufacturing Department Yu Wang Yang, Purchasing Department Yang Changyuan and Marketing Department Long Liwei spoke at the meeting as advanced representatives.
2
On the 5th, at the summary commendation meeting held by daye peak cement company, Zhang Fengliang, deputy general manager of the group company and general manager of daye peak cement company, made a 2020 work report, summarizing the progress made by daye peak during the 13th Five-Year Plan period from the aspects of increasing per capita labor productivity year by year, continuous growth of employee income, increasingly standardized enterprise management, and effective technological transformation. He analyzed the challenges brought about by the changes in the external environment of the cement industry in 2021, as well as the shortcomings in the internal management of the enterprise, and required middle-level managers not only to learn from others and learn from others, but also to learn management knowledge and improve themselves. Management ability, always pay attention to the development of domestic and foreign industries, and know their own equipment and technical level; all employees should have a strong sense of responsibility and mission, have passion for work, transmit positive energy, do not care about it, base on their own work, earnestly safeguard the interests of the enterprise, work conscientiously, unite sincerely, and achieve the same progress and common development of enterprises and individuals. Themeeting also awarded honorary certificates to advanced individuals and collectives, and advanced representatives Ke Quanjun and Liu Lin made speeches.
2# On the afternoon of July 7, at the summary and commendation meeting of Jianfeng Health Technology Company, employees gathered together to sum up the past and talk about the future. The peak health management team presented awards to advanced collectives, outstanding employees and "1 1" direct purchase outstanding marketers. Yin Zhiwu, general manager of Jianfeng Health, said that in 2021, Jianfeng Health will focus on the business idea of developing health products (health food and ordinary food), supplemented by plant extracts and Chinese herbal pieces. It will make concerted efforts to create the fist products of health products business, focus on the investment promotion agency sector, and complement entrusted processing, group purchase and retail terminals. Organize production and operation in strict accordance with GMP requirements and food regulations; Strictly pay attention to safety and environmental protection work, strive to be a safe and environmentally friendly accident-free factory.
2 On the 8th, the cable company used the morning meeting platform to summarize and commend. Zhang Ci, general manager of the cable company, made an annual work report for 2020, summarizing the outstanding highlights and achievements of the marketing department, production department, technology department and comprehensive finance department, and arranging the specific work ideas and efforts for 2021. Yu Jianhong, general manager of
Group Company, attended the meeting and presented awards to advanced collectives and outstanding employees. He congratulated the advanced collectives and individuals, affirmed the achievements of the cable company in 2020, and put forward requirements for the work of the cable company in 2021. He hopes that all employees of the cable company will establish confidence and make persistent efforts to believe that they can cope with external difficulties and have the ability to enable the cable company to achieve better benefits; further strengthen management and improve the level of technology; further increase market acceptance capabilities and improve technology Level, expand customer coverage, and enhance the reputation of cable companies. (qi jianmei, ni yingzhen, pan yi, wang yuhua, xu ying, zhou guangliang, xu feng, huang yuan)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31